tibolone has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brusselaers, N; Callens, S; Engstrand, L; Simin, J; Tamimi, RM | 1 |
| Huang, H; Pan, L; Shen, K; Wen, Y; Wu, M | 1 |
2 other study(ies) available for tibolone and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
Topics: Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Estrogens; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Ovarian Neoplasms; Progestins; Prospective Studies; Risk; Sweden | 2020 |
The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
Topics: Adolescent; Adult; Carcinoma, Ovarian Epithelial; Case-Control Studies; China; Disease-Free Survival; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Hormone Replacement Therapy; Humans; Kaplan-Meier Estimate; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Postoperative Period; Proportional Hazards Models; Retrospective Studies; Survival Rate; Young Adult | 2013 |